A new study by researchers at Intermountain Healthcare in Salt Lake City finds that alcohol consumption does not provide additional heart benefits in cardiology patients already being treated with statins – the most commonly used drugs to lower cholesterol.
A real-time electronic decision support system helped clinicians at community hospitals provide best practice care for emergency department patients with pneumonia, resulting in decreased intensive care unit admission, more appropriate antibiotic use, and 38% lower overall mortality according to a new study by researchers at Intermountain Healthcare in Salt Lake City.
New research from the Intermountain Healthcare Heart Institute in Salt Lake City finds that higher EPA blood levels alone lowered the risk of major cardiac events and death in patients, while DHA blunted the cardiovascular benefits of EPA. Higher DHA levels at any level of EPA worsened health outcomes, study finds.
In a prospectus review published this week in the Journal of Molecular and Cellular Cardiology, Kirk U. Knowlton MD, from the Intermountain Healthcare Heart Institute in Salt Lake City, examined more than 100 published studies related to COVID-19 and its effects on the heart.
A new study at Intermountain Primary Children’s Hospital in Salt Lake City has found that follow-up appointments for hospitalized children treated for childhood bronchitis are often not necessary, and that switching from mandatory to “as-needed” follow-up care can save families from unnecessary medical care and expense – and may help guide treatment during the COVID-19 pandemic.
Intermountain Healthcare has created two COVID-19 Response Teams with 50 caregivers each that will deploy to the New York City area to assist hospitals this week. Intermountain has partnered with New York-Presbyterian Hospital and Northwell Health, both located in the New York City area. These healthcare systems will aim to return the favor by supporting Intermountain as much as they can when Utah faces its own surge with COVID-19 patients.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs – hydroxychloroquine (HCQ) and azithromycin – to treat patients with COVID-19.
A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.
Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.
Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.
In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don’t.
In a new study presented to heart specialists from around the world, researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that simple “nudges” in the form of texts, emails and phone calls, not only help patients fill that first statin prescription, but also continue to help them take their medications over the long term.
From 20 minutes or more to 10 seconds. Researchers from Intermountain Healthcare and Stanford University say 10 seconds is about how quickly a new system they studied that utilizes artificial intelligence took to accurately identify key findings in chest X-rays of patients in the emergency department suspected of having pneumonia.
In a new study, researchers at Intermountain Healthcare in Salt Lake City found that steps measured through a step tracker worn on the wrist can be used to estimate exercise capacity and determine the health status of patients, rather than the standardized six-minute walk distance test, which is usually conducted in a clinical setting.
"We have a crisis in American healthcare right now," Dr. Harrison said. "Healthcare is unaffordable. The existing healthcare system is oriented toward driving volume. As an industry we do too many things to too many people that they really don't need, which hurts them economically, and sometimes physically. But Intermountain has a great history of innovation and together we can drive change." – Dr. Marc Harrison.
A new study by researchers at Intermountain Healthcare has found that administering broad-spectrum antibiotics, which act against a wide range of disease-causing bacteria, to treat patients with pneumonia often does more harm than good.
Intermountain Healthcare has earned top accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for ensuring the highest protections for participants in Intermountain clinical research studies.
Intermountain Healthcare and deCODE genetics have announced a major global collaboration and study focused on discovering new connections between genetics and human disease that will involve the collection of half a million DNA samples.
In a new study, researchers at Intermountain Healthcare in Salt Lake City found that antibiotic delivery was significantly faster — by up to 32 minutes — for sepsis patients being treated in an emergency department if they were assigned a slightly higher score on a subjective one-to-five acuity scale commonly used for patient triage.
Are electronic health records and computer calculations a better, more accurate way to predict clinical outcomes for patients with chronic obstructive pulmonary disease? According to the results of a new study by researchers at Intermountain Healthcare in Salt Lake City, the answer is yes.
Do family members of loved ones who are critically ill and being treated in an intensive care unit at a hospital belong there when clinicians are performing bedside procedures? New study finds many critical care clinicians have conflicting feelings about the practice.
A study of more than 17,000 patients finds a new laboratory-based method of estimating outcomes for patients with COPD may help physicians better provide proper care, referrals, and services for these patients at the end of life.
In a new study from the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have identified eight new gene mutations that may cause or contribute to idiopathic dilated cardiomyopathy, a form of heart disease not caused by known external influences, such as high blood pressure, obesity, smoking, or diseased coronary arteries.
In a new study from the Intermountain Healthcare Heart Institute in Salt Lake City, researchers found that performing catheter ablations on patients who suffer from both atrial fibrillation and carotid arterial disease reduces the risk of dementia and stroke compared to managing their care with medications.
Any time a pregnant woman presents in heart failure there are risks to both mother and baby. What does it take to protect the mother and her growing baby for the best possible outcome?
A new study has found that patients with atherosclerotic cardiovascular disease cut their risk of a second major adverse cardiovascular event by almost 50 percent, if they adhere to taking a statin medication as prescribed by their doctors.
A new research study presented at the American College Cardiology Scientific Sessions from the Intermountain Healthcare Heart Institute in Salt Lake City shows that identifying the presence or absence of coronary artery calcium (CAC) in a patients’ arteries can help determine their future risk.
Intermountain Healthcare has announced a new collaboration with Israeli healthcare IT company MDClone to increase caregivers’ ability to transform data into information they can use to help people lead the healthiest lives possible.
Intermountain Healthcare Precision Genomics has developed a new gene panel that will provide clinical utility to classify and diagnose certain types of blood cancers.
An electronic system developed and implemented by Intermountain Healthcare that monitors how physicians give blood to patients after a surgical operation has enabled the healthcare system to significantly reduce the amount of blood transfusions patients receive, cutting costs by $2.5 million over two years and contributing to lower infection rates without harming patients, according to a new study presented Wednesday at the 2015 Clinical Congress of the American College of Surgeons in Chicago.
Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease.
Physicians treating patients who complain of unexplained fatigue and tiredness with medications for depression and high blood pressure may be missing the underlying cause of their patients problems, according to a major new study.
A major new study by researchers at LDS Hospital shows that patients with acute carbon monoxide poisoning are significantly less likely to suffer long-term neurological and cognitive problems that can impair memory and concentration skills if they are treated promptly with highly-pressurized oxygen in a hyperbaric chamber.
The Winter Paralympic Games in Salt Lake City (March 7-16) produced 1,013 visits to 10 special medical clinics set up for the event, according to Intermountain Health Care, the medical services provider for the Games.
Of the 11,575 medical cases treated during the 2002 Winter Olympics, there were a few heart attacks, 16 instances of frostbite, and even 43 cases of altitude sickness. But overall, according to Intermountain Health Care, the medical services provider for the Games, most of the cases seen at Olympic clinics were not serious or life-threatening.
While Olympic competitors at the Salt Lake 2002 Winter Games are busy going for gold, a group of nine research teams will be busy trying to figure out how to improve athletes' performances at future competitions. For the scientists, Olympic athletes will serve as a large human lab for the duration of the Games in a unique opportunity to mix science and sport.
In commemoration of two unique events, the birth of a child and the 2002 Olympic Winter Games in Salt Lake City, IHC will send home all babies born in any of its hospitals during the Games wrapped in a special Olympic baby blanket. IHC is the medical services provider for the Games.
If you need to go to a hospital in Utah during the Olympics, they will be open to the public as usual. Intermountain Health Care, the medical services provider for the 2002 Olympic Winter Games, plans to have its facilities open and providing care just as they would any other time of the year.
With roughly 100,000 visitors per day expected in Utah during the 2002 Olympic Winter Games, as well as 3,500 athletes from 82 countries, what types of sicknesses are the medical services provider for the Games gearing up to treat?
When the 2002 Winter Olympics are held in Salt Lake City during February, hospitals operated by Intermountain Health Care will be ready for many types of emergencies. IHC is the medical services provider for the 2002 Winter Olympic and Paralympic Games.
If you take the three million bandages that will be used in providing medical services at various Olympic sites and lay them end-to-end, the bandages would stretch nearly the entire width of Utah. But bandages are just one small part of the numerous medical supplies that will be needed for the 2002 Olympic and Paralympic Games.
Four years ago, Intermountain Health Care was selected by the Salt Lake Organizing Committee to be the medical services provider for the 2002 Olympic and Paralympic Winter Games. Since then, a team from IHC has been working to develop and implement a plan to deliver those medical services.
A new study by researchers at Intermountain Health Care and HealthInsight has found that death rates and hospital admissions for patients with community-acquired pneumonia can be significantly reduced by using standardized treatment protocols that help caregivers more quickly and accurately diagnose the illness and begin treatment.
Diabetes is a known risk factor for mortality in patients with heart disease. Now a major new study by cardiac researchers at Intermountan Health Care's LDS Hospital has found heart disease patients who are not diabetic, but who have moderately elevated blood glucose levels, are also at significantly higher risk for death.
A study by cardiac researchers at Intermountain Health Care's LDS Hospital in Salt Lake City reveals that levels of a marker of inflammation called C-reactive protein actually do a better job of predicting who will benefit from medication and who will die among patients who already have coronary artery disease. (Journal of the American College of Cardiology, 11-00)
A number of infectious bugs -- including hepatitis A and herpes simplex virus types 1 and 2 -- are strongly associated with heart attacks and cardiovascular death, says LDS Hospital, Johns Hopkins University, and the Washington (DC) Hospital Center researchers.
A group of drugs that have been used commonly for the past five years to successfully lower cholesterol levels in people at risk for coronary artery disease may also provide a previously undocumented life-saving, anti-inflammatory effect for many patients, according to a new study by cardiac researchers at LDS Hospital in Salt Lake City.
Up to 25 percent of cases of insulin dependent diabetes mellitus that occur before age 15 may possibly be prevented by immunizing children with common pediatric vaccines at birth, rather than waiting until up to eight weeks of life, according to a new epidemiological study by researchers at Intermountain Health Care's LDS Hospital in Salt Lake City and Classen Immunotherapies in Baltimore, Maryland.
In a new three-year study published in Wednesday's issue of The Journal of the American Medical Association, researchers from Intermountain Health Care's LDS Hospital found that adverse drug reactions - on average - prolong hospitalizations by nearly two days, cost $2,262 each to treat, and almost double the risk of death for patients.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right